Immunotherapy in children and adolescents with allergic rhinoconjunctivitis: a systematic review

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Pediatric Allergy and Immunology

• Publication date

  2008-05-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/j.1399-3038.2007.00648.xPMID 18221463
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Sublingual immunotherapy for allergic rhinitis

  2010cited by this paper
• [Allergic rhinitis and its impact on asthma].

  2010cited by this paper
• Cochrane Handbook for Systematic Reviews of Interventions

  2010cited by this paper
• The Upper Airway A Prospective , Randomized , Double-blind , Placebo-Controlled Multi-centre Study on the Efficacy and Safety of Sublingual Immunotherapy ( SLIT ) in Children With Seasonal Allergic Rhinoconjunctivitis to Grass Pollen

  2006influential reference
• Clinical efficacy and safety of sublingual immunotherapy with tree pollen extract in children

  2006cited by this paper
• Sublingual immunotherapy: a comprehensive review.

  2006cited by this paper
• Efficacy of sublingual immunotherapy in the treatment of allergic rhinitis in pediatric patients 3 to 18 years of age: a meta-analysis of randomized, placebo-controlled, double-blind trials.

  2006influential reference
• Sublingual Immunotherapy for Allergic Rhinoconjunctivitis – The Seeming and the Real

  2005cited by this paper
• Wirksamkeit und Sicherheit der sublingualen Immuntherapie

  2005cited by this paper
• Efficacy of sublingual allergen vaccination for respiratory allergy in children. Conclusions from one meta-analysis.

  2005cited by this paper
• Coseasonal sublingual immunotherapy reduces the development of asthma in children with allergic rhinoconjunctivitis.

  2004influential reference
• Efficacy of sublingual swallow immunotherapy in children with severe grass pollen allergic symptoms: a double‐blind placebo‐controlled study

  2004influential reference
• A prospective, randomized, double‐blind, placebo‐controlled multi‐centre study on the efficacy and safety of sublingual immunotherapy (SLIT) in children with seasonal allergic rhinoconjunctivitis to grass pollen

  2004cited by this paper
• Sublingual immunotherapy in asthma and rhinoconjunctivitis; systematic review of paediatric literature

  2004cited by this paper
• Twelve-year survey of fatal reactions to allergen injections and skin testing: 1990-2001.

  2004cited by this paper
• Efficacy and safety of sublingual immunotherapy.

  2004cited by this paper
• Immunomodulation during sublingual therapy in allergic children

  2003influential reference
• Sublingual immunotherapy for allergic rhinitis.

  2003cited by this paper
• LOW-DOSE LOCAL NASAL IMMUNOTHERAPY IN CHILDREN WITH PERENNIAL ALLERGIC RHINITIS DUE TO DERMATOPHAGOIDES

  2003influential reference
• Impact of sublingual immunotherapy on seasonal asthma and skin reactivity in children allergic to Parietaria pollen treated with inhaled fluticasone propionate

  2003influential reference
• Updated Method Guidelines for Systematic Reviews in the Cochrane Collaboration Back Review Group

  2003cited by this paper
• Pollen immunotherapy reduces the development of asthma in children with seasonal rhinoconjunctivitis (the PAT-study).

  2002influential reference
• Low‐dose local nasal immunotherapy in children with perennial allergic rhinitis due to Dermatophagoides

  2002cited by this paper
• Development of a highly sensitive search strategy for the retrieval of reports of controlled trials using PubMed.

  2002cited by this paper
• Is sublingual immunotherapy clinically effective?

  2002cited by this paper
• Efficacy of sublingual immunotherapy in children with asthma and rhinitis: A double‐blind, placebo‐controlled study

  2001influential reference
• Allergic rhinitis and its impact on asthma.

  2001cited by this paper
• Preseasonal local allergoid immunotherapy to grass pollen in children: a double‐blind, placebo‐controlled, randomized trial

  2000influential reference
• LONG-TERM CLINICAL EFFICACY OF GRASS-POLLEN IMMUNOTHERAPY

  2000cited by this paper
• Double-blind placebo-controlled evaluation of sublingual-swallow immunotherapy with standardized Parietaria judaica extract in children with allergic rhinoconjunctivitis.

  1999influential reference
• Sublingual immunotherapy and influence on urinary leukotrienes in seasonal pediatric allergy.

  1999influential reference
• Immunotherapy as an effective tool in allergy treatment

  1998cited by this paper
• Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses?

  1998cited by this paper
• Allergen immunotherapy: therapeutic vaccines for allergic diseases. A WHO position paper.

  1998cited by this paper
• [WHO position paper. "Allergen immunotherapy: therapeutic vaccines for allergic diseases"].

  1998cited by this paper
• Double‐blind, placebo‐controlled evaluation of sublingual immunotherapy with standardized olive pollen extract in pediatric patients with allergic rhinoconjunctivitis and mild asthma due to olive pollen sensitization

  1998influential reference
• The Delphi list: a criteria list for quality assessment of randomized clinical trials for conducting systematic reviews developed by Delphi consensus.

  1998cited by this paper
• Allergen immunotherapy: therapeutic vaccines for allergic diseases

  1998cited by this paper
• Immunotherapy as an effective tool in allergy treatment.

  1998cited by this paper
• Immunotherapy with a standardized Dermatophagoides pteronyssinus extract. VI. Specific immunotherapy prevents the onset of new sensitizations in children.

  1997cited by this paper
• Double‐blind placebo‐controlled study of sublingual immunotherapy with house dust mite extract (D. pt.) in children

  1997influential reference
• Nasal immunotherapy in pollen‐sensitive children

  1997cited by this paper
• The CONSORT Statement

  1996cited by this paper
• Improving the quality of reporting of randomized controlled trials. The CONSORT statement.

  1996cited by this paper
• Local nasal immunotherapy with a powder extract for grass pollen induced rhinitis in pediatric ages: a controlled study.

  1996influential reference
• A three‐year double‐blind placebo‐controlled study with specific oral immunotherapy to Dermatophagoides: evidence of safety and efficacy in paediatric patients

  1994cited by this paper
• [House dust mite allergy].

  1991cited by this paper
• Oral immunotherapy with grass pollen in enterosoluble capsules

  1990influential reference
• Efficacy of sublingual immunotherapy in patients with rhinitis and asthma due to house dust mite. A double-blind study.

  1990influential reference
• A double-blind, multicenter immunotherapy trial in children, using a purified and standardized Cladosporium herbarum preparation. II. In vitro results.

  1987influential reference
• A Double‐Blind, Multicenter Immunotherapy Trial in Children, Using a Purified and Standardized Cladosporium herbarum Preparation I. Clinical Results

  1986cited by this paper
• Oral Immunotherapy of Children with Rhinoconjunctivitis due to Birch Pollen Allergy A Double Blind Study

  1986cited by this paper
• A controlled trial of oral hyposensitization in pollen asthma and rhinitis in children

  1984cited by this paper
• [Oral hyposensitization with pollen and placebo solution].

  1983cited by this paper
• [Efficacy of oral hyposensitization treatment in house dust mite allergy (author's transl)].

  1982cited by this paper
• [A new desensitization agent in the treatment of ragweed-induced seasonal allergic rhinitis (hay fever) in children: MRTA (modified ragweed tyrosine adsorbate)].

  1979cited by this paper
• Nasal hyposensitization and hay fever

  1975influential reference
• The treatment of seasonal hay fever and asthma in children. A controlled trial of pre-seasonal depot pollen therapy.

  1966influential reference
• Effectiveness of hyposensitization therapy in ragweed hay-fever in children.

  1966influential reference
• A Coefficient of Agreement for Nominal Scales

  1960cited by this paper

• International consensus statement on allergy and rhinology: Allergic rhinitis – 2023

  2023cites this paper
• Reliability of the Evidence Addressing Treatment of Corneal Diseases: A Summary of Systematic Reviews.

  2019cites this paper
• Management of ocular allergy

  2019influential citation
• Randomized double-blind placebo-controlled trial of sublingual immunotherapy in children with house dust mite allergy in primary care

  2019cites this paper
• International Consensus Statement on Allergy and Rhinology: Allergic Rhinitis

  2018cites this paper
• 国际过敏与鼻科学共识声明 : 变应性鼻炎

  2018cites this paper
• Efficacy and safety of sublingual immunotherapy with Dermatophagoides farinae drops in pre-school and school-age children with allergic rhinitis.

  2018cites this paper
• Allergen immunotherapy for allergic rhinoconjunctivitis: A systematic review and meta‐analysis

  2017cites this paper
• Allergen immunotherapy for allergic rhinoconjunctivitis: a systematic overview of systematic reviews

  2017influential citation
• Clinical practice recommendations for allergen-specific immunotherapy in children: the Italian consensus report

  2017cites this paper
• Efficacy and safety of sublingual immunotherapy in children

  2016cites this paper
• The effects of house dust mite sublingual immunotherapy in patients with allergic rhinitis according to duration

  2016cites this paper
• ITA aux allergènes saisonniers chez l’enfant : quelles sont les preuves d’efficacité ?

  2016cites this paper
• Sublingual immunotherapy in patients with house dust mite allergic rhinitis: prospective study of clinical outcomes over a two-year period

  2016cites this paper
• Guiding principles of sublingual immunotherapy for allergic rhinitis in Japanese patients.

  2016cites this paper
• Optimal duration of allergen immunotherapy in children with dust mite respiratory allergy

  2015cites this paper
• Clinical Considerations in the use of Sublingual Immunotherapy for Allergic Rhinitis

  2015cites this paper
• Tear and serum vitamin D levels in children with allergic rhinoconjunctivitis.

  2015cites this paper
• Immunotherapy in Allergic Rhinitis

  2015cites this paper
• Will Sublingual Immunotherapy Offer Benefit for Asthma?

  2013cites this paper
• The management of paediatric allergy: not everybody's cup of tea – 10–11th February 2012

  2013cites this paper
• A systematic review and economic evaluation of subcutaneous and sublingual allergen immunotherapy in adults and children with seasonal allergic rhinitis.

  2013cites this paper
• Allergen-Specific Immunotherapy for the Treatment of Allergic Rhinoconjunctivitis and/or Asthma: Comparative Effectiveness Review

  2013cites this paper
• Allergen-Specific Immunotherapy for Pediatric Asthma and Rhinoconjunctivitis: A Systematic Review

  2013cites this paper
• Are we prescribing too much or too little immunotherapy for children with allergic rhinitis?

  2012cites this paper
• Exposure to Dog Allergens and Subsequent Allergic Sensitization: An Updated Review

  2012cites this paper
• Immunotherapie voor inhalatieallergenen op de kinderleeftijd

  2012cites this paper
• Sublingual immunotherapy not effective in house dust mite–allergic children in primary care

  2012cites this paper
• House dust mite induced allergic rhinitis in children in primary care : Epidemiology and Management

  2012cites this paper
• Allergic rhinitis in children

  2012cites this paper
• T-cell responses during allergen-specific immunotherapy

  2012cites this paper
• Close collaboration between academia, industry and drug regulators is required in the development of allergen products for specific immunotherapy in children

  2011cites this paper
• [Indications and evidence base for specific immunotherapy in childhood].

  2011cites this paper
• En niños alérgicos con asma o rinitis, ¿es útil la inmunoterapia?

  2011cites this paper
• Inhalant Allergies in Children

  2011cites this paper
• Maintenance dosing for sublingual immunotherapy by prominent European allergen manufacturers expressed in bioequivalent allergy units.

  2011cites this paper
• Sublingual immunotherapy in children with allergic rhinitis: quality of systematic reviews

  2011cites this paper
• Evidence of effect of subcutaneous immunotherapy in children: complete and updated review from 2006 onward.

  2011cites this paper
• Evidence for Clinical Safety, Efficacy, and Parent and Physician Perceptions of Levocetirizine for the Treatment of Children with Allergic Disease

  2011cites this paper
• Indikationen und Studienlage zur spezifischen Immuntherapie im Kindes- und Jugendalter

  2011cites this paper
• Efficacy and safety of immunotherapy for allergies to Alternaria alternata in children.

  2011cites this paper
• The allergen challenge chamber: a valuable tool for optimizing the clinical development of pollen immunotherapy

  2011cites this paper
• Specific immunotherapy in children

  2011cites this paper
• Clinical immunology review series: an approach to desensitization

  2011cites this paper
• New approaches to the design of sublingual immunotherapy clinical trials

  2011cites this paper
• Towards evidence‐based medicine in specific grass pollen immunotherapy

  2010cites this paper
• Specific immunotherapy by the sublingual route for respiratory allergy

  2010cites this paper
• Current management of allergic rhinitis in children

  2010cites this paper
• Specific Immunotherapy (hyposensitization) for IgE-mediated allergic diseases*

  2010cites this paper
• Allergic Rhinitis and its Impact on Asthma (ARIA) 2010 Revision Full Online version - published in the Journal of Allergy and Clinical Immunology

  2010influential citation
• Sublingual immunotherapy for allergic rhinitis (Review)

  2010cites this paper
• Clinical safety and efficacy of bepotastine besilate ophthalmic solution to treat allergic conjunctivitis

  2010cites this paper
• Sublingual immunotherapy with house dust extract for house dust-mite allergic rhinitis in children.

  2010cites this paper
• T cell responses induced by allergen‐specific immunotherapy

  2010cites this paper
• Mechanisms of corneal allergic reaction: new options for treatment

  2010cites this paper
• Allergic Disease of the Conjunctiva and Cornea

  2010cites this paper
• Efficacité de l’immunothérapie dans l’asthme : comparaison des voies sous-cutanée et sublinguale☆

  2009cites this paper
• Sublingual immunotherapy in children: facts and needs

  2009cites this paper
• Efficacy and safety of 5-grass-pollen sublingual immunotherapy tablets in pediatric allergic rhinoconjunctivitis.

  2009cites this paper
• Allergic rhinitis.

  2009cites this paper
• Certainties and doubts about sublingual and oral immunotherapy in children

  2009cites this paper
• Sub-Lingual Immunotherapy

  2009cites this paper
• Sublingual immunotherapy for inhalant allergy: cautious optimism.

  2009cites this paper
• Safety and efficacy in children of an SQ-standardized grass allergen tablet for sublingual immunotherapy.

  2009cites this paper
• Sublingual immunotherapy in children: complete and updated review supporting evidence of effect

  2009cites this paper
• Spezifische Immuntherapie bei IgE-vermittelten allergischen Erkrankungen im Kindes- und Jugendalter – eine Übersicht über in Österreich zugelassene/registrierte Allergenpräparate

  2009cites this paper
• Sublingual immunotherapy in children: more optimism today

  2009cites this paper
• Sublingual immunotherapy: certainties, unmet needs and future directions.

  2009cites this paper
• Sublingual immunotherapy for children: Are we there yet? Defining its role in clinical practice.

  2009cites this paper
• Epicutaneous allergen administration as a novel method of allergen-specific immunotherapy.

  2009cites this paper
• Sublingual immunotherapy: where do we stand? Present and future.

  2009cites this paper
• Quoi de neuf en allergologie pédiatrique en 2007–2008 ? Partie 2 : allergie oculaire et respiratoire (une revue de la littérature internationale de septembre 2007–octobre 2008)

  2009cites this paper
• Bibliography. Current world literature.

  2009cites this paper
• En niños con rinoconjuntivitis estacional, una vacuna sublingual en comprimidos para gramíneas tiene una eficacia limitada

  2009cites this paper
• Selected problems of immunotherapy in children

  2009cites this paper
• CD‐sens: a biological measure of immunological changes stimulated by ASIT

  2009cites this paper
• Sub‐lingual Immunotherapy: World Allergy Organization Position Paper 2009

  2009cites this paper
• When to initiate immunotherapy in children with allergic disease? Lessons from the paediatric studies.

  2008cites this paper
• Sublingual immunotherapy: what have we learnt from the ‘big trials’?

  2008cites this paper
• When to initiate immunotherapy in children with allergic disease? Lessons from the paediatric studies

  2008cites this paper
• Immunotherapie op de kinderleeftijd

  2008cites this paper
• Sublingual immunotherapy in children

  2008cites this paper
• Subcutaneous and sublingual immunotherapy in children: Complete update on controversies, dosing, and efficacy

  2008influential citation
• Allergic rhinoconjunctivitis in children

  2007cites this paper
• Twelve‐year follow‐up after discontinuation of preseasonal grass pollen immunotherapy in childhood

  2006cites this paper
• A C I P O S I T I O N P A P E R Management of ocular allergy

  year unknowncites this paper